Skip to main content

ORBIMED ADVISORS LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1055951 New York, NY

Position in GILD

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$8,306,452
-$13,823,423 QoQ
Shares Held
59,600
-69.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Derivatives in GILD

reported options exposure · as of Dec 31, 2024
CallValue
$18,474,000
CallShares
200,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

ORBIMED ADVISORS LLC holds $634,822,752 across 5 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,306,452 59,600
2025-03-31 $22,129,875 197,500
2024-12-31 $18,474,000 200,000
2024-12-31 $22,686,072 245,600
2024-09-30 $12,718,528 151,700
2023-12-31 $8,101,000 100,000
2023-09-30 $7,494,000 100,000
2023-06-30 $7,707,000 100,000
2022-06-30 $17,776,556 287,600
2022-03-31 $17,097,820 287,600
2021-12-31 $20,882,636 287,600
2021-09-30 $20,088,860 287,600
2021-06-30 $19,804,136 287,600
2021-03-31 $18,587,588 287,600
2020-12-31 $11,197,572 192,200
2020-09-30 $12,145,118 192,200
2020-06-30 $14,787,868 192,200
2020-03-31 $109,979,436 1,471,100